Decreased vascular prostacyclin (PGI2) in diabetic rats. Stimulation of PGI2 release in normal and diabetic rats by the antithrombotic compound Bay g 6575.
D000818:Animals; D001011:Aorta / Q000503:physiopathology; D001786:Blood Glucose; D001835:Body Weight; D003404:Creatinine / Q000097:blood; D003921:Diabetes Mellitus, Experimental / Q000097:blood*; D011464:Epoprostenol / Q000097:blood*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D008297:Male; D011453:Prostaglandins / Q000097:blood*; D011720:Pyrazoles / Q000494:pharmacology*; D047069:Pyrazolones; D051381:Rats; D014508:Urea / Q000097:blood; D014556:Urine
D001786:Blood Glucose; D005343:Fibrinolytic Agents; D011453:Prostaglandins; D011720:Pyrazoles; D047069:Pyrazolones; D014508:Urea; D003404:Creatinine; D011464:Epoprostenol; C018845:nafazatrom